Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection

BACKGROUND: Cefiderocol is a recently licensed novel siderophore-conjugated cephalosporin stable to hydrolysis by serine and MBLs. It has been successfully used to treat Enterobacterales infections and is approved for the treatment of infections due to aerobic Gram-negative organisms in adults with...

Descripción completa

Detalles Bibliográficos
Autores principales: Mabayoje, Diana A, NicFhogartaigh, Caoimhe, Cherian, Benny P, Tan, Mei Gie Meiqi, Wareham, David W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251250/
https://www.ncbi.nlm.nih.gov/pubmed/34223152
http://dx.doi.org/10.1093/jacamr/dlab055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251250/
https://www.ncbi.nlm.nih.gov/pubmed/34223152
http://dx.doi.org/10.1093/jacamr/dlab055

Ejemplares similares